Low-dose treatment with Il2 across studies shows benefits in chronic graft-versus host
ATLANTA - Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host...
ATLANTA - Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host...
ATLANTA - Among younger patients newly diagnosed with chronic lymphocytic leukemia (CLL), treatment with a combination of chemotherapy and a...
PHILADELPHIA - Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the...
Credit: MD Anderson Cancer Center A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows...
PHILADELPHIA - In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell...
Credit: Loyola Medicine MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal...
ATLANTA -- Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma...
ATLANTA - In a Phase 1 trial, patients with an advanced or aggressive form of systemic mastocytosis (AdvSM), a rare...
ATLANTA - Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following...
ATLANTA - In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of...
ATLANTA - Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after...
Toward the end of life, some leukemia patients depend on blood transfusions to ease their suffering. Unfortunately, the likelihood that...
Credit: Seattle Children's SEATTLE - Dec. 9, 2017 - Results from a phase 2 clinical trial, presented by Seattle Children's...
SAN ANTONIO - Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to...
Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting...
SAN ANTONIO -- Younger breast cancer patients who underwent axillary lymph node dissection were more likely to experience arm swelling...
In families who carry certain inherited mutations that increase the risk for melanoma, members who do not carry the mutation...
Credit: Video courtesy of Jefferson Chan, University of Illinois CHAMPAIGN, Ill. -- Areas of hypoxia, or low oxygen in tissue,...
Darmstadt, December 8, 2017. The European Research Council awards an ERC Consolidator Grant to professor Heinz Koeppl and supports him...
Credit: MD Anderson Cancer Center In a randomized, Phase III trial led by researchers at The University of Texas MD...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.